| Primary |
| Asthma |
31.3% |
| Influenza |
25.0% |
| Chronic Obstructive Pulmonary Disease |
12.5% |
| Product Used For Unknown Indication |
12.5% |
| Bronchiolitis |
6.3% |
| Prophylaxis |
6.3% |
| Upper Respiratory Tract Infection |
6.3% |
|
| Pupils Unequal |
13.3% |
| Urinary Hesitation |
13.3% |
| Dysphonia |
6.7% |
| Eye Pain |
6.7% |
| Reaction To Drug Excipients |
6.7% |
| Renal Failure Acute |
6.7% |
| Respiratory Distress |
6.7% |
| Respiratory Failure |
6.7% |
| Restlessness |
6.7% |
| Suffocation Feeling |
6.7% |
| Swollen Tongue |
6.7% |
| Urticaria |
6.7% |
| White Blood Cell Count Decreased |
6.7% |
|
| Secondary |
| Product Used For Unknown Indication |
18.3% |
| Chronic Obstructive Pulmonary Disease |
16.8% |
| Hypertension |
9.9% |
| Lung Disorder |
6.1% |
| Pneumonia Aspiration |
6.1% |
| Agitation |
3.8% |
| Constipation |
3.8% |
| Pain |
3.8% |
| Pneumonia |
3.8% |
| Prophylaxis |
3.8% |
| Influenza |
3.1% |
| Blood Cholesterol Increased |
2.3% |
| Cough |
2.3% |
| Dyspnoea |
2.3% |
| Electrolyte Substitution Therapy |
2.3% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Muscle Spasms |
2.3% |
| Rhinorrhoea |
2.3% |
| Seasonal Allergy |
2.3% |
| Sedation |
2.3% |
|
| Urinary Retention |
15.4% |
| Dysphagia |
11.5% |
| White Blood Cell Count Decreased |
7.7% |
| Confusional State |
3.8% |
| Death |
3.8% |
| Heart Rate Increased |
3.8% |
| Hypernatraemia |
3.8% |
| Hypothyroidism |
3.8% |
| Hypoxia |
3.8% |
| Incorrect Route Of Drug Administration |
3.8% |
| Nausea |
3.8% |
| Pancytopenia |
3.8% |
| Pneumonia |
3.8% |
| Renal Tubular Necrosis |
3.8% |
| Respiratory Failure |
3.8% |
| Respiratory Tract Infection |
3.8% |
| Somnolence |
3.8% |
| Speech Disorder |
3.8% |
| Tachycardia |
3.8% |
| Temperature Intolerance |
3.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
37.0% |
| Product Used For Unknown Indication |
26.0% |
| Chronic Obstructive Pulmonary Disease |
6.9% |
| Asthma |
6.3% |
| Adverse Event |
3.6% |
| Pain |
2.8% |
| Hypertension |
2.3% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Prophylaxis |
1.4% |
| Diabetes Mellitus |
1.4% |
| Depression |
1.3% |
| Atrial Fibrillation |
1.2% |
| Dyspnoea |
1.2% |
| Anxiety |
1.2% |
| Emphysema |
1.2% |
| Pulmonary Arterial Hypertension |
1.0% |
| Plasma Cell Myeloma |
0.9% |
| Rheumatoid Arthritis |
0.9% |
| Constipation |
0.8% |
| Smoking Cessation Therapy |
0.8% |
|
| Pneumonia |
11.1% |
| Vomiting |
10.6% |
| Death |
6.8% |
| Weight Increased |
6.4% |
| Weight Decreased |
6.0% |
| Wheezing |
6.0% |
| White Blood Cell Count Increased |
6.0% |
| Renal Failure |
5.5% |
| Dyspnoea |
4.3% |
| Respiratory Failure |
4.3% |
| Product Quality Issue |
3.8% |
| Renal Failure Acute |
3.8% |
| Sepsis |
3.8% |
| Tremor |
3.4% |
| Urinary Tract Infection |
3.4% |
| Pulmonary Embolism |
3.0% |
| Thrombocytopenia |
3.0% |
| Thrombosis |
3.0% |
| Unevaluable Event |
3.0% |
| Vertigo |
3.0% |
|
